[Commentary on] Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer Journal Article
| Author: | Van Poznak, C. H. |
| Article Title: | [Commentary on] Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer |
| Keywords: | survival analysis; placebos; breast neoplasms -- drug therapy; random assignment; breast neoplasms -- mortality; female |
| Journal Title: | Women's Oncology Review |
| Volume: | 2 |
| Issue: | 4 |
| ISSN: | 1473-3404 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2002-12-01 |
| Start Page: | 447 |
| End Page: | 448 |
| Language: | English |
| ACCESSION: | 2004138651 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Accession Number: 2004138651 -- Entry Date: 20040820 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Powles T, Paterson S, Kanis JA, McCloskey E, Ashley S, Tidy A et al -- Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer -- J CLIN ONCOL 2002; 20: 3219-24 -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20 |
MSK Authors
-
52Van Poznak